If you liked this article you might like

S&P 500, Nasdaq Edge Higher as Crude Rebounds From Thursday Slump
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
Bluebird, Kite and Juno Delivering CAR-T Cancer Study Updates to ASCO '17 Meeting
Aduro Biotech, Merck Team on Cancer Drug Trial